A George Mason University researcher team has revealed the specific process by which the HIV virus infects healthy T cells—a process previously unknown. The principal investigator, HIV researcher Yuntao Wu, says he hopes ...
Biochemistry
Aug 24, 2011
0
0
(PhysOrg.com) -- The initial entry of HIV-1 into host cells remains a compelling yet elusive target for the development of agents to prevent infection, a critical need in the fight against the global AIDS epidemic.
Biochemistry
Jul 8, 2011
1
0
(PhysOrg.com) -- A new advance by UCLA biochemists has brought scientists one step closer to developing treatments that could delay the onset of Alzheimer's disease and prevent the sexual transmission of HIV.
Biochemistry
Jun 23, 2011
0
0
(PhysOrg.com) -- There is now a promising vaccine candidate for combating the pathogen which causes one of the most common and dangerous hospital infections. An international team of scientists from the Max Planck Institute ...
Biochemistry
May 31, 2011
0
0
Some people think of herbal teas, others of tobacco when they hear the buzzword "medicines from plants". One research team succeeded in producing biopharmaceuticals -- such as an antibody against HIV, for example, -- in tobacco ...
Biotechnology
May 26, 2011
0
0
(PhysOrg.com) -- Scientists at the University of Toronto and Stanford and Columbia Universities have developed a way to measure the action and function of candidate prescription drugs on human cells, including the response ...
Biochemistry
May 9, 2011
0
0
(PhysOrg.com) -- A University at Albany scientist's research in African chimpanzee populations may provide new insights into the natural history of simian immunodeficiency virus (SIVcpz), and the origins of HIV-AIDS.
Biotechnology
Mar 29, 2011
1
0
Human Immunodeficiency Virus (HIV) – which causes AIDS – invades human immune cells and causes them to produce new copies of the virus, which can then infect new cells. A research team led by Professor Don C. Lamb ...
Cell & Microbiology
Mar 11, 2011
0
0
MIT engineers have designed a new type of nanoparticle that could safely and effectively deliver vaccines for diseases such as HIV and malaria.
Bio & Medicine
Feb 22, 2011
0
0
In a paper published today in PNAS, scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, reveal new insights into the workings of enzymes from a group of bacteria including Mycobacterium tuberculosis, ...
Cell & Microbiology
Feb 15, 2011
0
0
